Tempus AI, Inc. Securities Lawsuit Investigation

Shamis & Gentile P.A., one of the nation's premier class action law firms specializing in securities fraud cases, is investigating potential claims against Tempus AI, Inc. (TEM).

If you purchased or held Tempus AI, Inc. securities between June 14, 2024 and May 27, 2025, you may be eligible to join this securities investigation and seek compensation for your losses.

About Tempus AI, Inc.

Tempus AI, Inc. (NASDAQ: TEM) is focused on precision medicine and healthcare artificial intelligence. The company uses advanced data analytics and machine learning to help doctors make more informed decisions, aiming to improve patient outcomes and streamline healthcare processes.

Headquartered in the United States, Tempus AI has positioned itself as an innovator in the healthcare sector. The company has reported strong revenue growth in recent quarters, largely driven by new partnerships and acquisitions. However, despite this growth, Tempus AI has continued to report net losses and has taken on increased debt to finance its expansion efforts.

The Allegations

The investigation centers on whether Tempus AI, Inc. and its management misled investors by making overly optimistic statements while failing to adequately disclose mounting financial risks.

During the proposed class period, investors were allegedly not informed about persistent net losses, lowered financial guidance, and the full extent of risks related to major acquisitions and increased debt.

Additionally, there are concerns about significant insider selling by company executives during this period. These sales occurred as Tempus AI was announcing new deals and raising additional capital, which may have signaled confidence to the market.

However, subsequent public disclosures in the first and second quarters of 2025 revealed disappointing financial results, new risk factors, and integration challenges. These revelations led to sharp declines in the company's stock price, causing substantial losses for investors.

The investigation is examining whether these actions violated federal securities laws and whether investors suffered losses as a result of misleading or incomplete information.

What is the Proposed Class Period?

The proposed class period for this investigation is from June 14, 2024 to May 27, 2025.

The class period is significant because it covers the dates when the alleged misrepresentations and omissions occurred, as well as when corrective disclosures were made. Investors who purchased or held Tempus AI, Inc. securities during this period may have been affected by the alleged misconduct and could be eligible to participate in any future class action lawsuit that may result from this investigation.

Your Rights and Next Steps

As an investor, you have the right to know whether you were affected by potential securities fraud. This is currently an investigation, not a filed lawsuit. Lawyers are ready to help you understand your legal options and determine whether you may be eligible to recover losses.

If you purchased or held Tempus AI, Inc. securities during the proposed class period, you can join the investigation. By doing so, you help ensure that your interests are represented if a class action lawsuit is filed. Participating in the investigation does not obligate you to anything, but it does allow you to stay informed and potentially benefit from any future recovery.

It is important to act quickly, as securities investigations are time-sensitive and important information may become unavailable as time passes.

You May Be Entitled to Compensation

Investors who purchased or held Tempus AI, Inc. securities between June 14, 2024 and May 27, 2025 may be eligible to join this securities investigation. If you suffered losses, you could be entitled to compensation if a class action lawsuit is filed and is successful.

Lawyers are ready to help guide you through the process and answer any questions you may have. To protect your rights and maximize your potential recovery, complete the below form to join the investigation.